Photo from wikipedia
Sarcopenia is a significant indicator of the severity of non‐alcoholic fatty liver disease. We investigated whether sarcopenia could identify subgroups with different risk of liver fibrosis and atherosclerotic cardiovascular disease… Click to show full abstract
Sarcopenia is a significant indicator of the severity of non‐alcoholic fatty liver disease. We investigated whether sarcopenia could identify subgroups with different risk of liver fibrosis and atherosclerotic cardiovascular disease (ASCVD) among subjects with metabolic dysfunction‐associated fatty liver disease (MAFLD).
Keywords:
subjects metabolic;
fatty liver;
among subjects;
metabolic dysfunction;
disease;
liver disease
Journal Title: Journal of Cachexia, Sarcopenia and Muscle
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Cachexia, Sarcopenia and Muscle
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!